![Peter Maag](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Maag
Directeur/Membre du Conseil chez
CAREDX, INC.
Fortune : 20 M $ au 30/09/2026
Profil
Peter K.
Maag currently serves as Independent Director at CareDx, Inc. since 2021.
He is Director at Personalized Medicine Coalition and Blulake Ventures LLC.
He is a Member of the Supervisory Board at PHOENIX Pharmahandel GmbH & Co. KG and PHOENIX Pharma SE since 2012.
Formerly, Dr. Maag was Chief Executive Officer & Director at Kyverna Therapeutics, Inc. from 2022 to 2024.
He was Independent Director at Miromatrix Medical, Inc. from 2021 to 2023.
He served as Director at MolecularMD Corp.
from 2012 to 2020.
He was Director at Zuellig Pharma Corp.
from 2003 to 2005.
He held multiple roles at Novartis International AG from 2001 to 2012, including Global Head-Novartis Diagnostics.
He was Global Head-Novartis Diagnostics at Novartis AG from 2009 to 2012 and Head-Strategy at Novartis AG from 2001 to 2002.
He was President at Novartis Vaccines & Diagnostics, Inc. from 2009 to 2012, President at Novartis Pharmaceuticals from 2006 to 2008, and Country President at Novartis Pharma AG from 2006 to 2008.
He was President at Novartis Korea Ltd. from 2003 to 2005 and President at Novartis Vaccines & Diagnostics SL.
He was Associate Principal at McKinsey GmbH & Co. KG from 1994 to 2001.
Dr. Maag earned a doctorate from Humboldt-Universität zu Berlin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAREDX, INC. 0,6 % | 31/03/2026 | 308 846 ( 0,6 % ) | 20 M $ | 30/09/2026 |
Postes actifs de Peter Maag
| Sociétés | Poste | Début |
|---|---|---|
| CAREDX, INC. | Directeur/Membre du Conseil | 01/11/2021 |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Directeur/Membre du Conseil | - |
Blulake Ventures LLC | Directeur/Membre du Conseil | - |
PHOENIX Pharma SE
 PHOENIX Pharma SE Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | 01/01/2012 |
PHOENIX Pharmahandel GmbH & Co. KG
 PHOENIX Pharmahandel GmbH & Co. KG Medical DistributorsDistribution Services Distributes pharmaceutical, health and medical products | Directeur/Membre du Conseil | 01/09/2012 |
Anciens postes connus de Peter Maag
| Sociétés | Poste | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur Général | 13/09/2024 |
| MIROMATRIX MEDICAL INC. | Directeur/Membre du Conseil | 11/12/2023 |
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics for oncology applications | Directeur/Membre du Conseil | 01/01/2020 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/04/2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Maag
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
CareDx, Inc.
 CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Miromatrix Medical, Inc.
 Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
PHOENIX Pharmahandel GmbH & Co. KG
PHOENIX Pharmahandel GmbH & Co. KG Medical DistributorsDistribution Services Distributes pharmaceutical, health and medical products | Distribution Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics for oncology applications | Health Services |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Commercial Services |
Zuellig Pharma Corp.
 Zuellig Pharma Corp. Medical DistributorsDistribution Services Provides distribution, digital and commercial services to support healthcare needs | Distribution Services |
Novartis Korea Ltd.
 Novartis Korea Ltd. Drugstore ChainsRetail Trade Sells pharmaceutical products | Retail Trade |
Novartis Vaccines & Diagnostics SL | |
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
PHOENIX Pharma SE
PHOENIX Pharma SE Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Blulake Ventures LLC |
